HER2-positive Breast Cancer Registry
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this observational study is to better understand links between patient or tumor characteristics and outcomes in HER2-positive breast cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rak piersi z dodatnim wynikiem HER2 w stadium I-IV
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 17, 2026
- Sex
- No restrictions
Locations (6)
KUCC - Indian Creek
Overland Park, United States
KUCC - Overland Park
Overland Park, United States
KUCC - Briarcliff
Westwood, United States
KUCC - Olathe
Westwood, United States
The University of Kansas Cancer Center
Westwood, United States
KUCC - Lee's Summit
Lee's Summit, United States
Trial contact
Study Coordinator
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.